- Home
- BNTX vs NTRS Comparison
BNTX vs NTRS Comparison
Compare BNTX & NTRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BNTX
- NTRS
- Stock Information
- Founded
- BNTX 2008
- NTRS 1889
- Country
- BNTX Germany
- NTRS United States
- Employees
- BNTX N/A
- NTRS N/A
- Industry
- BNTX Biotechnology: Biological Products (No Diagnostic Substances)
- NTRS Major Banks
- Sector
- BNTX Health Care
- NTRS Finance
- Exchange
- BNTX Nasdaq
- NTRS Nasdaq
- Market Cap
- BNTX 23.9B
- NTRS 22.3B
- IPO Year
- BNTX 2019
- NTRS N/A
- Fundamental
- Price
- BNTX $114.13
- NTRS $103.61
- Analyst Decision
- BNTX Strong Buy
- NTRS Hold
- Analyst Count
- BNTX 15
- NTRS 13
- Target Price
- BNTX $143.50
- NTRS $104.54
- AVG Volume (30 Days)
- BNTX 659.5K
- NTRS 1.4M
- Earning Date
- BNTX 11-04-2024
- NTRS 01-23-2025
- Dividend Yield
- BNTX N/A
- NTRS 2.90%
- EPS Growth
- BNTX N/A
- NTRS 51.89
- EPS
- BNTX N/A
- NTRS 8.00
- Revenue
- BNTX $3,390,698,192.00
- NTRS $7,857,600,000.00
- Revenue This Year
- BNTX N/A
- NTRS N/A
- Revenue Next Year
- BNTX N/A
- NTRS $3.32
- P/E Ratio
- BNTX N/A
- NTRS $12.95
- Revenue Growth
- BNTX N/A
- NTRS 16.78
- 52 Week Low
- BNTX $76.53
- NTRS $76.67
- 52 Week High
- BNTX $131.49
- NTRS $111.87
- Technical
- Relative Strength Index (RSI)
- BNTX 49.15
- NTRS 45.34
- Support Level
- BNTX $109.52
- NTRS $99.36
- Resistance Level
- BNTX $115.34
- NTRS $102.73
- Average True Range (ATR)
- BNTX 4.74
- NTRS 2.31
- MACD
- BNTX -0.80
- NTRS -0.79
- Stochastic Oscillator
- BNTX 29.03
- NTRS 37.81
About BNTX BioNTech SE
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including covid. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies; cell therapies; bispecific antibodies; and antibody-drug conjugates, or ADCs. BioNTech is partnered with several large pharmaceutical companies, including Roche, Eli Lilly, Pfizer, Sanofi, and Genmab. Covid vaccine Comirnaty is its first commercialized product.
About NTRS Northern Trust Corporation
Northern Trust is a leading provider of wealth management, asset servicing, asset management, and banking to corporations, institutions, affluent families, and individuals. Founded in Chicago in 1889, Northern Trust has offices in 20 states and Washington, D.C. as well as 23 locations in Canada, Europe, the Middle East, and Asia-Pacific. As of Dec. 31, 2023, Northern Trust had assets under custody or administration of $15.4 trillion and assets under management of $1.4 trillion.